NCT00694317View on ClinicalTrials.gov

Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Short Term Treatment of Insomnia
Interventions
DRUG

Zaleplon

Short term treatment of insomnia

Trial Locations (1)

77042

Novum Pharmaceutical Research Services, Houston

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00694317 - Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed Conditions | Biotech Hunter | Biotech Hunter